ARCUS BIOSCIENCES INC (RCUS) Forecast, Price Target & Analyst Ratings

NYSE:RCUS • US03969F1093

Current stock price

22.34 USD
-0.94 (-4.04%)
At close:
22.34 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARCUS BIOSCIENCES INC (RCUS).

Forecast Snapshot

Consensus Price Target

Price Target
$34.88
+ 56.15% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.92
Revenue Estimate
26.334M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
81.11%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$34.88
Upside
+ 56.15%
From current price of $22.34 to mean target of $34.88, Based on 18 analyst forecasts
Low
$20.20
Median
$31.62
High
$51.45

Price Target Revisions

1 Month
5.88%
3 Months
6.54%

Price Target Summary

18 Wall Street analysts provided a forecast for the next 12 months for RCUS. The average price target is 34.88 USD. This implies a price increase of 56.15% is expected in the next year compared to the current price of 22.34.
The average price target has been revised upward by 6.54% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

RCUS Current Analyst RatingRCUS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

RCUS Historical Analyst RatingsRCUS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
81.11%
RCUS was analyzed by 18 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RCUS.
In the previous month the buy percentage consensus was at a similar level.
RCUS was analyzed by 18 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-02WedbushMaintains Outperform -> Outperform
2026-03-05CitigroupMaintains Buy -> Buy
2026-03-02Leerink PartnersMaintains Outperform -> Outperform
2026-03-02HC Wainwright & Co.Reiterate Buy -> Buy
2026-02-12Wells FargoDowngrade Overweight -> Equal-Weight
2026-01-13Goldman SachsUpgrade Neutral -> Buy
2026-01-08Morgan StanleyDowngrade Overweight -> Equal-Weight
2025-12-12HC Wainwright & Co.Maintains Buy -> Buy
2025-11-28B of A SecuritiesMaintains Neutral -> Neutral
2025-10-30Goldman SachsMaintains Neutral -> Neutral
2025-10-29CitigroupMaintains Buy -> Buy
2025-10-29HC Wainwright & Co.Maintains Buy -> Buy
2025-10-20Wells FargoMaintains Overweight -> Overweight
2025-10-13CitigroupMaintains Buy -> Buy
2025-10-07Truist SecuritiesReiterate Buy -> Buy
2025-08-07Wells FargoMaintains Overweight -> Overweight
2025-05-09Morgan StanleyMaintains Overweight -> Overweight
2025-05-08Goldman SachsMaintains Neutral -> Neutral
2025-05-07Wells FargoMaintains Overweight -> Overweight
2025-04-23BarclaysMaintains Overweight -> Overweight
2025-02-26HC Wainwright & Co.Upgrade Neutral -> Buy
2025-02-19B of A SecuritiesMaintains Neutral -> Neutral
2025-02-18Morgan StanleyMaintains Overweight -> Overweight
2025-02-18HC Wainwright & Co.Maintains Neutral -> Neutral
2024-11-06HC Wainwright & Co.Reiterate Neutral -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.92
Revenue Estimate
26.334M
Revenue Q2Q
-5.95%
EPS Q2Q
19.12%
Number of Analysts
12

Next Earnings Revisions

Revenue (1 Month)
-4.23%
Revenue (3 Months)
7.18%
EPS (1 Month)
5.69%
EPS (3 Months)
20.70%

Next Earnings Summary

RCUS is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.92 USD and the consensus revenue estimate is 26.33M USD.
The next earnings revenue estimate has been revised upward by 7.18% in the past 3 months. Upward revisions are a positive sign and indicate that analysts are more optimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RCUS revenue by date.RCUS revenue by date.
117M
4.46%		258M
120.51%		247M
-4.26%		84.293M
-65.87%		154.45M
83.23%		247.07M
59.97%		517.37M
109.40%		995.6M
92.43%		1.458B
46.44%		2.028B
39.09%		2.486B
22.58%
EBITDA
YoY % growth
RCUS ebitda by date.RCUS ebitda by date.
-332M
-21.17%		-300M
9.64%		-376M
-25.33%		-476.376M
-26.70%		-391.342M
17.85%		-289.582M
26.00%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
RCUS ebit by date.RCUS ebit by date.
-340M
-21.43%		-310M
8.82%		-386M
-24.52%		-483.032M
-25.14%		-443.765M
8.13%		-285.324M
35.70%		-112.556M
60.55%		179.09M
259.11%		395.1M
120.62%		657.33M
66.37%		904.24M
37.56%
Operating Margin
RCUS operating margin by date.RCUS operating margin by date.
-290.60%-120.16%-156.28%-573.04%-287.32%-115.48%-21.76%17.99%27.10%32.41%36.37%
EPS
YoY % growth
RCUS eps by date.RCUS eps by date.
-4.15
-11.56%		-3.10
25.30%		-3.30
-6.45%		-4.02
-21.68%		-3.41
15.02%		-2.86
16.32%		-0.94
67.02%		0.70
174.37%		2.54
263.33%		3.70
45.49%		4.82
30.30%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28
EPS
Q2Q % growth		-0.92
19.12%		-0.94-0.98
22.64%		-0.96
-8.27%		-1.02
-10.62%		-1.00
-6.77%		-1.00
-1.74%		-0.81
16.38%		-0.52
48.80%		-0.32
68.16%		-0.20
80.31%
Revenue
Q2Q % growth		26.334M
-5.95%		24.385M
-84.76%		19.772M
-23.95%		21.245M
-35.62%		30.173M
14.58%		21.478M
-11.92%		38.356M
93.99%		52.416M
146.72%		106.13M
251.74%		149.99M
598.34%		178.76M
366.05%
EBITDA
Q2Q % growth		-114.966M
3.39%		-119.286M
-3,876.19%		-120.363M
10.84%		-119.168M
-14.58%		N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-111.002M
9.02%		-113.599M
-1,319.99%		-122.074M
14.03%		-120.561M
-5.76%		N/AN/AN/AN/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

RCUS Yearly Revenue VS EstimatesRCUS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B
RCUS Yearly EPS VS EstimatesRCUS Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 -4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
4.30%
EPS Next 5 Year
17.21%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
-0.59%
Revenue Next 5 Year
31.68%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
8.12%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ARCUS BIOSCIENCES INC / RCUS Forecast FAQ

What is the average price target for ARCUS BIOSCIENCES INC (RCUS) stock?

18 analysts have analysed RCUS and the average price target is 34.88 USD. This implies a price increase of 56.15% is expected in the next year compared to the current price of 22.34.

What is the next earnings date for RCUS stock?

ARCUS BIOSCIENCES INC (RCUS) will report earnings on 2026-05-04, after the market close.

What are the consensus estimates for ARCUS BIOSCIENCES INC (RCUS) next earnings?

The consensus EPS estimate for the next earnings of ARCUS BIOSCIENCES INC (RCUS) is -0.92 USD and the consensus revenue estimate is 26.33M USD.

How many analysts have analysed ARCUS BIOSCIENCES INC (RCUS)?

The number of analysts covering ARCUS BIOSCIENCES INC (RCUS) is 18.